A Lifetime of Aldosterone Excess: Long-Term Consequences of Altered Regulation of Aldosterone Production for Cardiovascular Function
The DOI matches its Crossref record; 245 of the 249 references it cites were found in a registry or an index.
Abstract
Up to 15% of patients with essential hypertension have inappropriate regulation of aldosterone; although only a minority have distinct adrenal tumors, recent evidence shows that mineralocorticoid receptor activation contributes to the age-related blood pressure rise and illustrates the importance of aldosterone in determining cardiovascular risk. Aldosterone also has a major role in progression and outcome of ischemic heart disease. These data highlight the need to understand better the regulation of aldosterone synthesis and its action. Aldosterone effects are mediated mainly through classical nuclear receptors that alter gene transcription. In classic epithelial target tissues, signaling mechanisms are relatively well defined. However, aldosterone has major effects in nonepithelial tissues that include increased synthesis of proinflammatory molecules and reactive oxygen species; it remains unclear how these effects are controlled and how receptor specificity is maintained. Variation in aldosterone production reflects interaction of genetic and environmental factors. Although the environmental factors are well understood, the genetic control of aldosterone synthesis is still the subject of debate. Aldosterone synthase (encoded by the CYP11B2 gene) controls conversion of deoxycorticosterone to aldosterone. Polymorphic variation in CYP11B2 is associated with increased risk of hypertension, but the molecular mechanism that accounts for this is not known. Altered 11beta-hydroxylase efficiency (conversion of deoxycortisol to cortisol) as a consequence of variation in the neighboring gene (CYP11B1) may be important in contributing to altered control of aldosterone synthesis, so that the risk of hypertension may reflect a digenic effect, a concept that is discussed further. There is evidence that a long-term increase in aldosterone production from early life is determined by an interaction of genetic and environmental factors, leading to the eventual phenotypes of aldosterone-associated hypertension and cardiovascular damage in middle age and beyond. The importance of aldosterone has generated interest in its therapeutic modulation. Disadvantages associated with spironolactone (altered libido, gynecomastia) have led to a search for alternative mineralocorticoid receptor antagonists. Of these, eplerenone has been shown to reduce cardiovascular risk after myocardial infarction. The benefits and disadvantages of this therapeutic approach are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Primary aldosteronism (PA) is associated with increased risk for dysglycemia.”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [7]
Citations
Cites
Items 201–245 of 245
Mineralocorticoid Receptor Activation and Oxidative Stress
Funder, J. W. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.098012 · Cited by 55
Mitochondrial regulation of mineralocorticoid biosynthesis by calcium and the StAR protein
Cherradi, N., Brandenburger, Y., & Capponi, A. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1390249 · Cited by 55
Keavney, B. D., Mayosi, B. M., Gaukrodger, N., Imrie, H., Baker, M., Fraser, R., Ingram, M. C., Watkins, H. C., Farrall, M., Davies, E., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0870 · Cited by 54
Self-citationYamazaki, T., Higuchi, K., Kominami, S., & Takemori, S. (1996) · Endocrinology · doi:10.1210/endo.137.7.8770885 · Cited by 53
Regulation of adrenal steroidogenesis during chronic stress
Aguilera, G., Kiss, A., Lu, A., & Camacho, C. (1996) · Endocrine Research · doi:10.1080/07435809609043729 · Cited by 53
Mineralocorticoid Action and Sodium-Hydrogen Exchange: Studies in Experimental Cardiac Fibrosis
Young, M. J., & Funder, J. W. (2003) · Endocrinology · doi:10.1210/en.2003-0039 · Cited by 51
Do Human Vascular Endothelial Cells Produce Aldosterone?
Ahmad, N., Romero, D. G., Gomez-Sanchez, E. P., & Gomez-Sanchez, C. E. (2004) · Endocrinology · doi:10.1210/en.2004-0081 · Cited by 50
Renin Subgroups in Essential Hypertension
Drayer, J. I. M., Weber, M. A., Laragh, J. H., & Sealey, J. E. (1982) · Clinical and Experimental Hypertension · doi:10.3109/10641968209061643 · Cited by 49
Treatment of Hypertension With Spironolactone
Wolf, R. L. (1966) · JAMA · doi:10.1001/jama.1966.03110240051022 · Cited by 49
McDougal, J. G., Butkus, A., Coghlan, J. P., Denton, D. A., Müller, J., Oddie, C. J., Robinson, P. M., & Scoggins, B. A. (1980) · European Journal of Endocrinology · doi:10.1530/acta.0.0940559 · Cited by 48
Cover, C. M., Wang, J., Lezin, E. S., Kurtz, T. W., & Mellon, S. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16555 · Cited by 47
A Role for the NGFI‐B Family in Adrenal Zonation and Adrenocortical Disease
Bassett, M. H., White, P. C., & Rainey, W. E. (2004) · Endocrine Research · doi:10.1081/erc-200043715 · Cited by 44
Fuchs-Hammoser, R., Schweiger, M., & Oelkers, W. (1980) · Acta Endocrinologica · doi:10.1530/acta.0.0950198 · Cited by 44
Yamazaki, T., Kimoto, T., Higuchi, K., Ohta, Y., Kawato, S., & Kominami, S. (1998) · Endocrinology · doi:10.1210/endo.139.12.6338 · Cited by 44
Davies, E., Holloway, C. D., Ingram, M. C., Friel, E. C., Inglis, G. C., Swan, L., Hillis, W. S., Fraser, R., & Connell, J. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01264.x · Cited by 43
Self-citationPossible Role of 18-Hydroxy-deoxy-corticosterone in Hypertension
Rapp, J. P., & Dahl, L. K. (1972) · Nature · doi:10.1038/237338a0 · Cited by 43
Regulation of aldosterone biosynthesis: Physiological and clinical aspects
Müller, J. (1988) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(88)90655-x · Cited by 42
Polymorphic Variation in the 11β-Hydroxylase Gene Associates With Reduced 11-Hydroxylase Efficiency
Barr, M., MacKenzie, S. M., Friel, E. C., Holloway, C. D., Wilkinson, D. M., Brain, N. J. R., Ingram, M. C., Fraser, R., Mj, B., Samani, N. J., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000249904.93940.7a · Cited by 42
Self-citationProlonged ACTH infusion suppresses aldosterone secretion in spite of high renin activity
Oelkers, W., Harendt, H., & Exner, P. (1985) · European Journal of Endocrinology · doi:10.1530/acta.0.1080091 · Cited by 41
Characterization of human trophoblast as a mineralocorticoid target tissue
Driver, P. M., Rauz, S., Walker, E. A., Hewison, M., Kilby, M. D., & Stewart, P. M. (2003) · Molecular Human Reproduction · doi:10.1093/molehr/gag091 · Cited by 40
Tissue-specific corticosteroidogenesis in the rat
Rudolph, A. E., Blasi, E. R., & Delyani, J. A. (2000) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00258-6 · Cited by 37
Mechanisms of ACTH(cAMP)-dependent transcription of adrenal steroid hydroxylases
Waterman, M. R., & Bischof, L. J. (1996) · Endocrine Research · doi:10.1080/07435809609043755 · Cited by 35
Corticosteroid Production by Fetal Rat Hippocampal Neurons
Mackenzie, S. M., Clark, C. J., Ingram, M. C., Lai, M., Seckl, J., Gomez-Sanchez, C. E., Fraser, R., Connell, J. M. C., & Davies, E. (2000) · Endocrine Research · doi:10.3109/07435800009048566 · Cited by 35
Self-citationAldosterone-induced vasculopathy
Struthers, A. D. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.024 · Cited by 35
Freel, E. M., Ingram, M. C., Friel, E. C., Fräser, R., Mj, B., Samani, N. J., Caulfield, M. J., Munroe, P. B., Farrall, M., Webster, J., et al. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02971.x · Cited by 35
Self-citationTanahashi, H., Mune, T., Takahashi, Y., Isaji, M., Suwa, T., Morita, H., Yamakita, N., Yasuda, K., Deguchi, T., White, P. C., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0299 · Cited by 34
The Effect of Administered ACTH on Aldosterone Metabolism and Secretion
Pratt, J. H., Dale, S. L., & Melby, J. C. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-42-2-355 · Cited by 33
THE MYTH OF IDIOPATHIC HYPERALDOSTERONISM
Padfield, P., Davies, D. L., Lever, A., Brown, J., Fraser, R., Morton, J., & Robertson, J. I. S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90424-4 · Cited by 32
Self-citationTranscardiac extraction of circulating endothelin-1 across the failing heart
Tsutamoto, T., Wada, A., Maeda, K., Mabuchi, N., Hayashi, M., Tsutsui, T., Ohnishi, M., Sawaki, M., Fujii, M., Matsumoto, T., et al. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01006-7 · Cited by 32
ACTH-induced inhibition of the action of angiotensin II in bovine zona glomerulosa cells
Yoshida, A., Nishikawa, T., Tamura, Y., & Yoshida, S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)64320-4 · Cited by 31
Griffing, G. T., Berelowitz, B. A., Hudson, M., Salzman, R. T., Manson, J. E., Aurecchia, S. A., Melby, J. C., Pedersen, R. C., & Brownie, A. C. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111941 · Cited by 31
CYP11B2-CYP11B1 Haplotypes Associated with Decreased 11β-Hydroxylase Activity
Ganapathipillai, S., Laval, G., Hoffmann, I., Castejon, A. M., Nicod, J., Dick, B., Frey, F. J., Frey, B. M., Cubeddu, L. X., & Ferrari, P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1031 · Cited by 30
Association between Aldosterone Production and Variation in the 11β-Hydroxylase (CYP11B1) Gene
Imrie, H., Freel, M., Mayosi, B. M., Davies, E., Fraser, R., Ingram, M. C., Cordell, H. J., Farrall, M., Avery, P. J., Watkins, H. C., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1481 · Cited by 29
Self-citationLocal renin-angiotensin systems and their interactions with extra-adrenal corticosteroid production
MacKenzie, S. M., Fraser, R., Connell, J. M., & Davies, E. (2002) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2002.043 · Cited by 27
Self-citationStudies on the control of aldosterone secretion in man
James, V. H. T., Tunbridge, R. D. G., & Wilson, G. A. (1976) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(76)90016-9 · Cited by 25
Zhou, M., Gomez-Sanchez, E. P., Foecking, M. F., & Gomez-Sanchez, C. E. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03653-o · Cited by 22
Arola, J. T., Heikkilä, P., Voutilainen, R., & Kahri, A. I. (1993) · Journal of Endocrinology · doi:10.1677/joe.0.1390451 · Cited by 21
Mildly raised corticosterone excretion rates in patients with essential hypertension.
Soro, A., Ingram, M. C., Tonolo, G., Glorioso, N., & Fraser, R. (1995) · PubMed · Cited by 19
Self-citationArola, J. T., Heikkilä, P., Voutilainen, R., & Kahri, A. I. (1994) · Journal of Endocrinology · doi:10.1677/joe.0.1410285 · Cited by 16
Steroids, hypertension and cardiac fibrosis.
Funder, J. W. (1995) · PubMed · Cited by 16
Beevers, D. G., Brown, J. J., Cuesta, V., Davies, D. L., Fräser, R., Lebel, M., Lever, A. F., Morton, J. J., Oelkers, W., Robertson, J. I., et al. (1975) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(75)90067-9 · Cited by 15
Time series analysis of hormonal patterns in human plasma
Vagnucci, A. H., Wong, A. K. C., & Liu, T. S. (1974) · Computers and Biomedical Research · doi:10.1016/0010-4809(74)90029-9 · Cited by 14
Regulation of aldosterone biosynthesis; physiological and clinical aspects
(1988) · International Journal of Biochemistry · doi:10.1016/s0020-711x(98)90022-2 · Cited by 3
Acute aldosterone responses to ACTH predict both cortisol responses and blood pressure
Reynolds, R. M., Walker, B. R., Phillips, D. H., Syddall, H. E., Davies, E., Fraser, R., & Connell, J. (2007) · Society for Endocrinology BES · Cited by 2
Self-citationBornstein, S., Ehrhart‐Bornstein, M., & Scherbaum, W. (1996) · European Journal of Endocrinology · doi:10.1530/eje.0.1350739 · Cited by 2
Cited by
Vitamin D status and arterial hypertension: a systematic review
Pilz, S., Tomaschitz, A., Ritz, E., & Pieber, T. R. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.135 · Cited by 406
“Mechanistic links with blood pressure The renin–angiotensin–aldosterone system Increased activation of the renin–angiotensin–aldosterone system (RAAS), which is a main regulator of electrolyte and volume homeostasis, contributes to the development of arterial hypertension”
BackgroundUpdate on tissue renin–angiotensin systems
Bader, M., & Ganten, D. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0336-0 · Cited by 293
“Mineralocorticoid receptor antagonists turned out to decrease the risk after myocardial infarction [59, 60 ].”
BackgroundParthasarathy, H. K., Ménard, J., White, W. B., Young, W. F., Williams, G. H., Williams, B., Ruilope, L. M., McInnes, G. T., Connell, J. M., & MacDonald, T. M. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283455ca5 · Cited by 281
Self-citationBlood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis
Burgaz, A., Orsini, N., Larsson, S. C., & Wolk, A. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834320f9 · Cited by 247
Amar, L., Azizi, M., Menard, J., Peyrard, S., Watson, C., & Plouin, P.-F. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.157271 · Cited by 202
Metadata
- Authors
- Connell, J. M. C., MacKenzie, S. M., Freel, E. M., Fraser, R., & Davies, E.
- Affiliations
- British Heart Foundation (GB)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2008-02-21
- Volume
- 29
- Issue
- 2
- Pages
- 133-154
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W1977973738
- Semantic Scholar
- a5e9ead66dd474017e77ece0053f5ef285c2b773
- Cited by
- 182
- References
- 249
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 10 · 2023: 7 · 2022: 4 · 2021: 7 · 2020: 5 · 2019: 5 · 2018: 4 · 2017: 10 · 2016: 13 · 2015: 5 · 2014: 13 · 2013: 11 · 2012: 20
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- British Heart Foundation
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- aldosterone excess, essential hypertension, mineralocorticoid receptor, cardiovascular risk, aldosterone synthase, CYP11B2, CYP11B1, 11β-hydroxylase, ischemic heart disease, proinflammatory molecules, reactive oxygen species, genetic and environmental factors, spironolactone, eplerenone, mineralocorticoid receptor antagonists, myocardial infarction
- MeSH terms
- Aldosterone, Animals, Cardiovascular Physiological Phenomena, Humans, Hyperaldosteronism, Hypertension, Renal, Renin-Angiotensin System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.